Nefopam

RAHWAY, N.J., July 15, 2026 Merck has announced that its blockbuster PD-1 inhibitor KEYTRUDA® (pembrolizumab) achieved the primary endpoint...

CHENGDU, China, July 15, 2026 Kelun-Biotech and Harbour BioMed have announced that China’s National Medical Products Administration (NMPA) has...

MALVERN, Pa., July 15, 2026 MAXONA Pharmaceuticals has received U.S. FDA Investigational New Drug (IND) clearance to initiate a...